Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.96939357 |
2 | negative T cell selection (GO:0043383) | 6.53058599 |
3 | negative thymic T cell selection (GO:0045060) | 6.23753661 |
4 | response to interleukin-15 (GO:0070672) | 5.90394135 |
5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.87332463 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.76151347 |
7 | locomotory exploration behavior (GO:0035641) | 5.75960346 |
8 | cellular response to interleukin-15 (GO:0071350) | 5.75048400 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.58564154 |
10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.56138224 |
11 | positive T cell selection (GO:0043368) | 5.47998486 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45911181 |
13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.45081893 |
14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.44095183 |
15 | synaptic vesicle maturation (GO:0016188) | 5.40166933 |
16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.34096379 |
17 | vocalization behavior (GO:0071625) | 5.31433134 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 5.29919411 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25107313 |
20 | synaptic vesicle exocytosis (GO:0016079) | 5.22726788 |
21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.20035104 |
22 | activated T cell proliferation (GO:0050798) | 5.06167113 |
23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.04680451 |
24 | T cell migration (GO:0072678) | 5.03024766 |
25 | interferon-gamma production (GO:0032609) | 5.02969103 |
26 | negative regulation of T cell mediated immunity (GO:0002710) | 5.02362700 |
27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.99803846 |
28 | positive thymic T cell selection (GO:0045059) | 4.99499409 |
29 | T cell selection (GO:0045058) | 4.97792579 |
30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.97689895 |
31 | thymic T cell selection (GO:0045061) | 4.94230235 |
32 | glutamate secretion (GO:0014047) | 4.91543478 |
33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.91366982 |
34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.89645842 |
35 | protein localization to synapse (GO:0035418) | 4.79679818 |
36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.78821015 |
37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75203924 |
38 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.69976441 |
39 | glutamate receptor signaling pathway (GO:0007215) | 4.69105674 |
40 | leukocyte aggregation (GO:0070486) | 4.68171694 |
41 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.63975617 |
42 | exploration behavior (GO:0035640) | 4.63515360 |
43 | tolerance induction (GO:0002507) | 4.62438610 |
44 | neuronal action potential propagation (GO:0019227) | 4.60698138 |
45 | positive regulation of granulocyte differentiation (GO:0030854) | 4.56352964 |
46 | synaptic transmission, glutamatergic (GO:0035249) | 4.48104685 |
47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.40527217 |
48 | regulation of synaptic vesicle transport (GO:1902803) | 4.38979440 |
49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.38674449 |
50 | regulation of synapse structural plasticity (GO:0051823) | 4.36891425 |
51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.34420659 |
52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.33968079 |
53 | neuron-neuron synaptic transmission (GO:0007270) | 4.33874659 |
54 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.30149747 |
55 | long-term memory (GO:0007616) | 4.22908477 |
56 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.12456848 |
57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.12343600 |
58 | regulation of synaptic plasticity (GO:0048167) | 4.11317332 |
59 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.10274691 |
60 | long-term synaptic potentiation (GO:0060291) | 4.09051669 |
61 | regulation of postsynaptic membrane potential (GO:0060078) | 4.03783425 |
62 | neuron cell-cell adhesion (GO:0007158) | 3.99187740 |
63 | neurotransmitter secretion (GO:0007269) | 3.93803433 |
64 | B cell receptor signaling pathway (GO:0050853) | 3.93233887 |
65 | positive regulation of membrane potential (GO:0045838) | 3.92135390 |
66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89544038 |
67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85410731 |
68 | dendritic spine morphogenesis (GO:0060997) | 3.82622702 |
69 | regulation of T cell tolerance induction (GO:0002664) | 3.82210855 |
70 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.79968257 |
71 | behavioral defense response (GO:0002209) | 3.79560353 |
72 | behavioral fear response (GO:0001662) | 3.79560353 |
73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.79424364 |
74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.79424364 |
75 | response to histamine (GO:0034776) | 3.79247570 |
76 | cellular potassium ion homeostasis (GO:0030007) | 3.78074219 |
77 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.73591265 |
78 | regulation of regulatory T cell differentiation (GO:0045589) | 3.69184489 |
79 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.67227944 |
80 | T cell receptor signaling pathway (GO:0050852) | 3.63360313 |
81 | alpha-beta T cell differentiation (GO:0046632) | 3.58062758 |
82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.57598129 |
83 | regulation of B cell differentiation (GO:0045577) | 3.57136477 |
84 | T cell homeostasis (GO:0043029) | 3.56689655 |
85 | negative regulation of cell killing (GO:0031342) | 3.54984825 |
86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54984825 |
87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.54925360 |
88 | chemosensory behavior (GO:0007635) | 3.53951117 |
89 | positive regulation of neurotransmitter transport (GO:0051590) | 3.52395046 |
90 | fear response (GO:0042596) | 3.50468527 |
91 | positive regulation of synapse maturation (GO:0090129) | 3.50111838 |
92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.47765800 |
93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.47466494 |
94 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.46934082 |
95 | long term synaptic depression (GO:0060292) | 3.46154964 |
96 | synaptic vesicle endocytosis (GO:0048488) | 3.45151132 |
97 | regulation of dendritic spine development (GO:0060998) | 3.42361147 |
98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.41586726 |
99 | behavioral response to cocaine (GO:0048148) | 3.39069620 |
100 | transmission of nerve impulse (GO:0019226) | 3.38246880 |
101 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.38002846 |
102 | positive regulation of interleukin-2 production (GO:0032743) | 3.36122237 |
103 | regulation of glutamate secretion (GO:0014048) | 3.35659138 |
104 | proline transport (GO:0015824) | 3.35627706 |
105 | dendritic spine organization (GO:0097061) | 3.35010806 |
106 | synaptic transmission, dopaminergic (GO:0001963) | 3.34370389 |
107 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.34148537 |
108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.33917140 |
109 | alpha-beta T cell activation (GO:0046631) | 3.33639826 |
110 | layer formation in cerebral cortex (GO:0021819) | 3.32961312 |
111 | sodium ion export (GO:0071436) | 3.32932693 |
112 | neuron recognition (GO:0008038) | 3.32715699 |
113 | neuromuscular process controlling balance (GO:0050885) | 3.32195266 |
114 | membrane depolarization (GO:0051899) | 3.32080949 |
115 | regulation of vesicle fusion (GO:0031338) | 3.30407915 |
116 | activation of protein kinase A activity (GO:0034199) | 3.30094865 |
117 | innervation (GO:0060384) | 3.30070858 |
118 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.29423559 |
119 | learning (GO:0007612) | 3.29344364 |
120 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.27010389 |
121 | positive regulation of B cell differentiation (GO:0045579) | 3.26320584 |
122 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.26319695 |
123 | response to amphetamine (GO:0001975) | 3.25822897 |
124 | NIK/NF-kappaB signaling (GO:0038061) | 3.25301078 |
125 | regulation of neurotransmitter secretion (GO:0046928) | 3.24875174 |
126 | prepulse inhibition (GO:0060134) | 3.24657328 |
127 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.23981453 |
128 | regulation of tolerance induction (GO:0002643) | 3.22592194 |
129 | regulation of cell killing (GO:0031341) | 3.22346265 |
130 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.20786915 |
131 | cellular extravasation (GO:0045123) | 3.20183994 |
132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.19184790 |
133 | gamma-aminobutyric acid transport (GO:0015812) | 3.18708312 |
134 | positive regulation of synaptic transmission (GO:0050806) | 3.17987381 |
135 | positive regulation of tolerance induction (GO:0002645) | 3.17937296 |
136 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.16683266 |
137 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.15248117 |
138 | neurotransmitter transport (GO:0006836) | 3.15223727 |
139 | regulation of female receptivity (GO:0045924) | 3.14543140 |
140 | Peyers patch development (GO:0048541) | 3.12921016 |
141 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.12921016 |
142 | negative regulation of adaptive immune response (GO:0002820) | 3.12067438 |
143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11447573 |
144 | positive regulation of cell killing (GO:0031343) | 3.10938782 |
145 | T cell differentiation (GO:0030217) | 3.10423280 |
146 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.09049508 |
147 | negative regulation of amino acid transport (GO:0051956) | 3.08404589 |
148 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.08400564 |
149 | regulation of synaptic transmission (GO:0050804) | 3.08169617 |
150 | T cell costimulation (GO:0031295) | 3.07245481 |
151 | regulation of alpha-beta T cell activation (GO:0046634) | 3.06668490 |
152 | cellular response to type I interferon (GO:0071357) | 3.05932339 |
153 | type I interferon signaling pathway (GO:0060337) | 3.05932339 |
154 | striatum development (GO:0021756) | 3.04683609 |
155 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04503781 |
156 | membrane depolarization during action potential (GO:0086010) | 3.04328150 |
157 | response to type I interferon (GO:0034340) | 3.04306765 |
158 | positive regulation of dendritic spine development (GO:0060999) | 3.03561276 |
159 | lymphocyte costimulation (GO:0031294) | 3.03072432 |
160 | regulation of interleukin-2 production (GO:0032663) | 3.02851502 |
161 | regulation of neurotransmitter transport (GO:0051588) | 3.02626045 |
162 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.02224311 |
163 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01717804 |
164 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01084091 |
165 | axonal fasciculation (GO:0007413) | 3.00638671 |
166 | lymphocyte migration (GO:0072676) | 2.99913665 |
167 | T-helper cell differentiation (GO:0042093) | 2.99801304 |
168 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.99801304 |
169 | regulation of granulocyte differentiation (GO:0030852) | 2.98917369 |
170 | regulation of neurotransmitter levels (GO:0001505) | 2.98701402 |
171 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.98477867 |
172 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.98117069 |
173 | negative regulation of dendrite development (GO:2000171) | 2.97725598 |
174 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.97348334 |
175 | serotonin metabolic process (GO:0042428) | 2.97263284 |
176 | signal complex assembly (GO:0007172) | 2.96843326 |
177 | synaptic transmission (GO:0007268) | 2.96708801 |
178 | T cell differentiation involved in immune response (GO:0002292) | 2.94789319 |
179 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.94789319 |
180 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.94789319 |
181 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94455885 |
182 | modulation by symbiont of host defense response (GO:0052031) | 2.94455885 |
183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94455885 |
184 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94455885 |
185 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94455885 |
186 | modulation by symbiont of host immune response (GO:0052553) | 2.94455885 |
187 | * mast cell activation (GO:0045576) | 2.93688586 |
188 | positive regulation of humoral immune response (GO:0002922) | 2.93054033 |
189 | natural killer cell differentiation (GO:0001779) | 2.93022250 |
190 | visual learning (GO:0008542) | 2.92897668 |
191 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.92324607 |
192 | auditory behavior (GO:0031223) | 2.92154678 |
193 | regulation of ARF protein signal transduction (GO:0032012) | 2.90480703 |
194 | lymphocyte homeostasis (GO:0002260) | 2.88023084 |
195 | detection of bacterium (GO:0016045) | 2.86896998 |
196 | negative regulation of interleukin-12 production (GO:0032695) | 2.85888190 |
197 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.85410940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.80353060 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.21751476 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41042327 |
4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.18291084 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61451839 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.58312815 |
7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.50011989 |
8 | * MYB_26560356_Chip-Seq_TH2_Human | 3.22962658 |
9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.20459384 |
10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14571301 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.13641305 |
12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08148239 |
13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.03883232 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00143713 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98917597 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91320642 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81287240 |
18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.77653288 |
19 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72869701 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68877089 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68877089 |
22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.58642182 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57242623 |
24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.55060793 |
25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53649021 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.52734787 |
27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48260290 |
28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44947832 |
29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42069618 |
30 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40209125 |
31 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.39575075 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 2.33448384 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33277560 |
34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23439814 |
35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22820599 |
36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21308760 |
37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21248167 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.18651583 |
39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18062604 |
40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13775176 |
41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05468693 |
42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04845437 |
43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01044809 |
44 | MYC_22102868_ChIP-Seq_BL_Human | 1.97527540 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97361357 |
46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93774328 |
47 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88315504 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.87806250 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83336457 |
50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81172066 |
51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79861011 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79493771 |
53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77498421 |
54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77402637 |
55 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.76172135 |
56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75435763 |
57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.74535112 |
58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74146011 |
59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73235803 |
60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70704675 |
61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69126395 |
62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68414350 |
63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63313762 |
64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58104780 |
65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53792462 |
66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53498453 |
67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48433327 |
68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48139566 |
69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47091991 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46928138 |
71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43756387 |
72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43358896 |
73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43078530 |
74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38707642 |
75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37701101 |
76 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36906083 |
77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36750992 |
78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34310953 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33316271 |
80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33159299 |
81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32682963 |
82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32619192 |
83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31944792 |
84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31558337 |
85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31447951 |
86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27594431 |
87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27047917 |
88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26728102 |
89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26360714 |
90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24968459 |
91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23589306 |
92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23239165 |
93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23169955 |
94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23167666 |
95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22376109 |
96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20972516 |
97 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20448002 |
98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19011657 |
99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18825218 |
100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17889699 |
101 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17618526 |
102 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17470826 |
103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15787269 |
104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15548022 |
105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15490130 |
106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15301725 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15112204 |
108 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14929486 |
109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14390132 |
110 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14380923 |
111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13929275 |
112 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12734961 |
113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10920033 |
114 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10161015 |
115 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09902717 |
116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08315521 |
117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07692312 |
118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07678850 |
119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07625046 |
120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07530428 |
121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07518458 |
122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07176914 |
123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07026487 |
124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06101787 |
125 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05538440 |
126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05465064 |
127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05101307 |
128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04872040 |
129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02646030 |
130 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.01916462 |
131 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01593442 |
132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01559400 |
133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01031541 |
134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00669088 |
135 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00549590 |
136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00001733 |
137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99695053 |
138 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99691622 |
139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99403665 |
140 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98638783 |
141 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.97702628 |
142 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97600837 |
143 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97303463 |
144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96715731 |
145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96304372 |
146 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95782577 |
147 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94873577 |
148 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94251794 |
149 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93726181 |
150 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93563303 |
151 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93224508 |
152 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93145223 |
153 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91340434 |
154 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90168700 |
155 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89670891 |
156 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89219191 |
157 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88759787 |
158 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88660780 |
159 | JUN_21703547_ChIP-Seq_K562_Human | 0.88646394 |
160 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87918151 |
161 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87888163 |
162 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87218864 |
163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86136556 |
164 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85636741 |
165 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84919866 |
166 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84761890 |
167 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84656624 |
168 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84054544 |
169 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82276069 |
170 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81082098 |
171 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80937047 |
172 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79265526 |
173 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78284964 |
174 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77025537 |
175 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75687392 |
176 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75437012 |
177 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75103433 |
178 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72660574 |
179 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72473634 |
180 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70889918 |
181 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69327235 |
182 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69175280 |
183 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67447421 |
184 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67238373 |
185 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67017885 |
186 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.65317417 |
187 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64241781 |
188 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.63777133 |
189 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.62501801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.60172389 |
2 | MP0003880_abnormal_central_pattern | 5.50994961 |
3 | MP0003763_abnormal_thymus_physiology | 4.85488045 |
4 | MP0003635_abnormal_synaptic_transmissio | 4.48169676 |
5 | MP0005671_abnormal_response_to | 4.02778102 |
6 | MP0002822_catalepsy | 4.00905771 |
7 | MP0004270_analgesia | 3.84225253 |
8 | MP0009745_abnormal_behavioral_response | 3.80389679 |
9 | MP0002063_abnormal_learning/memory/cond | 3.72617088 |
10 | MP0001835_abnormal_antigen_presentation | 3.38325335 |
11 | * MP0001800_abnormal_humoral_immune | 3.35640384 |
12 | MP0002064_seizures | 3.32415051 |
13 | MP0005387_immune_system_phenotype | 3.31803874 |
14 | MP0001790_abnormal_immune_system | 3.31803874 |
15 | MP0001968_abnormal_touch/_nociception | 3.29782110 |
16 | MP0002572_abnormal_emotion/affect_behav | 3.02505680 |
17 | MP0000685_abnormal_immune_system | 2.96984745 |
18 | * MP0005000_abnormal_immune_tolerance | 2.91229952 |
19 | MP0003724_increased_susceptibility_to | 2.89186045 |
20 | MP0003300_gastrointestinal_ulcer | 2.88590567 |
21 | MP0003436_decreased_susceptibility_to | 2.82468293 |
22 | * MP0002723_abnormal_immune_serum | 2.75614193 |
23 | MP0001501_abnormal_sleep_pattern | 2.72255821 |
24 | MP0002736_abnormal_nociception_after | 2.69589619 |
25 | MP0009046_muscle_twitch | 2.68561950 |
26 | MP0002272_abnormal_nervous_system | 2.66253357 |
27 | * MP0002420_abnormal_adaptive_immunity | 2.62838424 |
28 | MP0004381_abnormal_hair_follicle | 2.62449344 |
29 | MP0003866_abnormal_defecation | 2.59039910 |
30 | * MP0001819_abnormal_immune_cell | 2.58532388 |
31 | MP0001486_abnormal_startle_reflex | 2.53341223 |
32 | MP0009785_altered_susceptibility_to | 2.51324619 |
33 | * MP0002452_abnormal_antigen_presenting | 2.49160596 |
34 | MP0005025_abnormal_response_to | 2.38073452 |
35 | MP0009333_abnormal_splenocyte_physiolog | 2.34622698 |
36 | * MP0002398_abnormal_bone_marrow | 2.33359072 |
37 | MP0002734_abnormal_mechanical_nocicepti | 2.32740739 |
38 | MP0002735_abnormal_chemical_nociception | 2.29337362 |
39 | * MP0000703_abnormal_thymus_morphology | 2.26364515 |
40 | MP0001873_stomach_inflammation | 2.19538795 |
41 | MP0006082_CNS_inflammation | 2.17009214 |
42 | * MP0000716_abnormal_immune_system | 2.15510215 |
43 | MP0001440_abnormal_grooming_behavior | 2.13881052 |
44 | MP0005423_abnormal_somatic_nervous | 2.12823742 |
45 | MP0002405_respiratory_system_inflammati | 2.12664588 |
46 | MP0002419_abnormal_innate_immunity | 2.01497462 |
47 | MP0010155_abnormal_intestine_physiology | 1.95887970 |
48 | MP0002148_abnormal_hypersensitivity_rea | 1.95784037 |
49 | MP0001970_abnormal_pain_threshold | 1.92661820 |
50 | * MP0000689_abnormal_spleen_morphology | 1.91645621 |
51 | MP0003329_amyloid_beta_deposits | 1.90536054 |
52 | MP0002733_abnormal_thermal_nociception | 1.89288505 |
53 | MP0008569_lethality_at_weaning | 1.85736314 |
54 | MP0002067_abnormal_sensory_capabilities | 1.84067072 |
55 | * MP0002722_abnormal_immune_system | 1.83041043 |
56 | MP0009780_abnormal_chondrocyte_physiolo | 1.77685750 |
57 | MP0002909_abnormal_adrenal_gland | 1.75628647 |
58 | MP0004811_abnormal_neuron_physiology | 1.72677668 |
59 | MP0005386_behavior/neurological_phenoty | 1.71909918 |
60 | MP0004924_abnormal_behavior | 1.71909918 |
61 | MP0002396_abnormal_hematopoietic_system | 1.65171050 |
62 | MP0002138_abnormal_hepatobiliary_system | 1.64531761 |
63 | * MP0001845_abnormal_inflammatory_respons | 1.63810414 |
64 | * MP0002429_abnormal_blood_cell | 1.62038153 |
65 | MP0001529_abnormal_vocalization | 1.61850578 |
66 | MP0003879_abnormal_hair_cell | 1.59985682 |
67 | MP0004947_skin_inflammation | 1.59856117 |
68 | MP0002557_abnormal_social/conspecific_i | 1.59394616 |
69 | MP0002166_altered_tumor_susceptibility | 1.59209857 |
70 | MP0002184_abnormal_innervation | 1.57317635 |
71 | MP0004510_myositis | 1.54530412 |
72 | MP0005646_abnormal_pituitary_gland | 1.53001491 |
73 | MP0004858_abnormal_nervous_system | 1.51915928 |
74 | MP0003787_abnormal_imprinting | 1.51430309 |
75 | MP0003633_abnormal_nervous_system | 1.47145641 |
76 | MP0005075_abnormal_melanosome_morpholog | 1.43642012 |
77 | MP0000778_abnormal_nervous_system | 1.38778268 |
78 | MP0001984_abnormal_olfaction | 1.36997172 |
79 | MP0001851_eye_inflammation | 1.33387422 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.32351954 |
81 | MP0003075_altered_response_to | 1.31415478 |
82 | MP0000015_abnormal_ear_pigmentation | 1.29859569 |
83 | MP0001905_abnormal_dopamine_level | 1.29243845 |
84 | MP0008874_decreased_physiological_sensi | 1.27921962 |
85 | MP0008057_abnormal_DNA_replication | 1.27123479 |
86 | MP0002009_preneoplasia | 1.26934538 |
87 | MP0000955_abnormal_spinal_cord | 1.25649666 |
88 | MP0005409_darkened_coat_color | 1.25382890 |
89 | MP0002163_abnormal_gland_morphology | 1.24889261 |
90 | MP0002006_tumorigenesis | 1.21001071 |
91 | MP0002882_abnormal_neuron_morphology | 1.20110611 |
92 | MP0005464_abnormal_platelet_physiology | 1.18519243 |
93 | MP0002928_abnormal_bile_duct | 1.18224336 |
94 | MP0006276_abnormal_autonomic_nervous | 1.18162846 |
95 | MP0008872_abnormal_physiological_respon | 1.17987993 |
96 | MP0003631_nervous_system_phenotype | 1.14869618 |
97 | MP0001502_abnormal_circadian_rhythm | 1.11335969 |
98 | MP0001188_hyperpigmentation | 1.11147514 |
99 | MP0002933_joint_inflammation | 1.10901172 |
100 | MP0004885_abnormal_endolymph | 1.07924518 |
101 | MP0000465_gastrointestinal_hemorrhage | 1.04427905 |
102 | MP0005535_abnormal_body_temperature | 1.02750059 |
103 | MP0000604_amyloidosis | 1.02410318 |
104 | MP0005645_abnormal_hypothalamus_physiol | 1.02048367 |
105 | MP0008961_abnormal_basal_metabolism | 1.01001681 |
106 | MP0001533_abnormal_skeleton_physiology | 0.97695205 |
107 | MP0008469_abnormal_protein_level | 0.97206915 |
108 | MP0002277_abnormal_respiratory_mucosa | 0.95884596 |
109 | MP0003183_abnormal_peptide_metabolism | 0.94887367 |
110 | MP0001348_abnormal_lacrimal_gland | 0.94618898 |
111 | MP0010234_abnormal_vibrissa_follicle | 0.93531807 |
112 | MP0002069_abnormal_eating/drinking_beha | 0.92743501 |
113 | MP0002152_abnormal_brain_morphology | 0.91075635 |
114 | MP0008877_abnormal_DNA_methylation | 0.87158874 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.85844800 |
116 | MP0008260_abnormal_autophagy | 0.85534189 |
117 | MP0002693_abnormal_pancreas_physiology | 0.84750290 |
118 | MP0004484_altered_response_of | 0.84451722 |
119 | MP0004808_abnormal_hematopoietic_stem | 0.82277550 |
120 | MP0001853_heart_inflammation | 0.82163771 |
121 | MP0009764_decreased_sensitivity_to | 0.81359521 |
122 | MP0001663_abnormal_digestive_system | 0.80920440 |
123 | MP0003252_abnormal_bile_duct | 0.80905500 |
124 | MP0004142_abnormal_muscle_tone | 0.78848178 |
125 | MP0000920_abnormal_myelination | 0.78508850 |
126 | MP0001177_atelectasis | 0.77084222 |
127 | MP0004883_abnormal_blood_vessel | 0.76036135 |
128 | MP0004085_abnormal_heartbeat | 0.76008917 |
129 | MP0002229_neurodegeneration | 0.75974257 |
130 | MP0000013_abnormal_adipose_tissue | 0.75951992 |
131 | MP0002837_dystrophic_cardiac_calcinosis | 0.75876104 |
132 | MP0005310_abnormal_salivary_gland | 0.75244366 |
133 | MP0010386_abnormal_urinary_bladder | 0.73360086 |
134 | MP0002998_abnormal_bone_remodeling | 0.73354415 |
135 | MP0000569_abnormal_digit_pigmentation | 0.71794314 |
136 | MP0005166_decreased_susceptibility_to | 0.70659543 |
137 | MP0004742_abnormal_vestibular_system | 0.68339566 |
138 | MP0000490_abnormal_crypts_of | 0.67549207 |
139 | MP0001986_abnormal_taste_sensitivity | 0.66057207 |
140 | MP0003690_abnormal_glial_cell | 0.65501510 |
141 | MP0005174_abnormal_tail_pigmentation | 0.64663894 |
142 | MP0004145_abnormal_muscle_electrophysio | 0.64132148 |
143 | MP0001765_abnormal_ion_homeostasis | 0.63698260 |
144 | MP0000751_myopathy | 0.63393117 |
145 | MP0005499_abnormal_olfactory_system | 0.63167197 |
146 | MP0005394_taste/olfaction_phenotype | 0.63167197 |
147 | MP0001963_abnormal_hearing_physiology | 0.63136230 |
148 | MP0001664_abnormal_digestion | 0.62315264 |
149 | MP0002019_abnormal_tumor_incidence | 0.61407268 |
150 | MP0003828_pulmonary_edema | 0.60982773 |
151 | MP0005379_endocrine/exocrine_gland_phen | 0.58070367 |
152 | MP0003634_abnormal_glial_cell | 0.58057565 |
153 | MP0003632_abnormal_nervous_system | 0.56533533 |
154 | MP0002132_abnormal_respiratory_system | 0.55269124 |
155 | MP0005451_abnormal_body_composition | 0.54479452 |
156 | MP0002876_abnormal_thyroid_physiology | 0.53889618 |
157 | MP0000858_altered_metastatic_potential | 0.53358625 |
158 | MP0005551_abnormal_eye_electrophysiolog | 0.52973960 |
159 | MP0003303_peritoneal_inflammation | 0.52814592 |
160 | MP0004215_abnormal_myocardial_fiber | 0.52431513 |
161 | MP0003045_fibrosis | 0.50984532 |
162 | MP0002090_abnormal_vision | 0.50371666 |
163 | MP0001485_abnormal_pinna_reflex | 0.50228529 |
164 | MP0003122_maternal_imprinting | 0.49085002 |
165 | MP0009765_abnormal_xenobiotic_induced | 0.48552545 |
166 | MP0009763_increased_sensitivity_to | 0.48348381 |
167 | MP0001919_abnormal_reproductive_system | 0.47404080 |
168 | MP0003191_abnormal_cellular_cholesterol | 0.46186490 |
169 | MP0003956_abnormal_body_size | 0.45828684 |
170 | MP0003172_abnormal_lysosome_physiology | 0.44277874 |
171 | MP0001943_abnormal_respiration | 0.43621586 |
172 | MP0002752_abnormal_somatic_nervous | 0.43519220 |
173 | MP0010769_abnormal_survival | 0.42766179 |
174 | MP0010768_mortality/aging | 0.40009250 |
175 | MP0004130_abnormal_muscle_cell | 0.39472103 |
176 | MP0000631_abnormal_neuroendocrine_gland | 0.38547860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.24014687 |
2 | Myokymia (HP:0002411) | 7.86603758 |
3 | T lymphocytopenia (HP:0005403) | 6.54898658 |
4 | Focal seizures (HP:0007359) | 6.46702255 |
5 | Abnormality of T cell number (HP:0011839) | 6.09078835 |
6 | Visual hallucinations (HP:0002367) | 5.29574776 |
7 | Epileptic encephalopathy (HP:0200134) | 5.12213576 |
8 | Stomatitis (HP:0010280) | 5.09606509 |
9 | Atonic seizures (HP:0010819) | 4.98375199 |
10 | Febrile seizures (HP:0002373) | 4.87048047 |
11 | Absence seizures (HP:0002121) | 4.73645380 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.62005216 |
13 | Optic neuritis (HP:0100653) | 4.62005216 |
14 | Abnormality of T cells (HP:0002843) | 4.55814200 |
15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.50717916 |
16 | Eczematoid dermatitis (HP:0000976) | 4.50431771 |
17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.49562196 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.49562196 |
19 | Myositis (HP:0100614) | 4.47062042 |
20 | Recurrent fungal infections (HP:0002841) | 4.46743988 |
21 | Dialeptic seizures (HP:0011146) | 4.34530560 |
22 | Progressive cerebellar ataxia (HP:0002073) | 4.22357006 |
23 | Generalized tonic-clonic seizures (HP:0002069) | 4.19089426 |
24 | Hyperventilation (HP:0002883) | 4.14025408 |
25 | Orchitis (HP:0100796) | 4.13058403 |
26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04510918 |
27 | Severe combined immunodeficiency (HP:0004430) | 4.02420027 |
28 | Panhypogammaglobulinemia (HP:0003139) | 3.93495733 |
29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.91863096 |
30 | Broad-based gait (HP:0002136) | 3.90207131 |
31 | Action tremor (HP:0002345) | 3.89239438 |
32 | IgG deficiency (HP:0004315) | 3.78884096 |
33 | Poor eye contact (HP:0000817) | 3.78805237 |
34 | Autoimmune hemolytic anemia (HP:0001890) | 3.73505596 |
35 | Recurrent bacterial skin infections (HP:0005406) | 3.65690630 |
36 | Encephalitis (HP:0002383) | 3.61402341 |
37 | Gaze-evoked nystagmus (HP:0000640) | 3.60462911 |
38 | Recurrent viral infections (HP:0004429) | 3.58475920 |
39 | Recurrent bronchitis (HP:0002837) | 3.57089533 |
40 | Meningitis (HP:0001287) | 3.56634172 |
41 | Dysmetria (HP:0001310) | 3.51321046 |
42 | Amblyopia (HP:0000646) | 3.50297022 |
43 | Vasculitis (HP:0002633) | 3.45828362 |
44 | Chronic diarrhea (HP:0002028) | 3.45540401 |
45 | Supranuclear gaze palsy (HP:0000605) | 3.45101934 |
46 | Mediastinal lymphadenopathy (HP:0100721) | 3.44988223 |
47 | Increased IgM level (HP:0003496) | 3.43912299 |
48 | Impaired social interactions (HP:0000735) | 3.42765110 |
49 | Abnormal social behavior (HP:0012433) | 3.42765110 |
50 | Truncal ataxia (HP:0002078) | 3.42699369 |
51 | Depression (HP:0000716) | 3.39283163 |
52 | Lymphopenia (HP:0001888) | 3.37464119 |
53 | Recurrent abscess formation (HP:0002722) | 3.36841628 |
54 | Keratoconjunctivitis sicca (HP:0001097) | 3.31712619 |
55 | Pustule (HP:0200039) | 3.29899235 |
56 | Anxiety (HP:0000739) | 3.29008728 |
57 | Recurrent skin infections (HP:0001581) | 3.25186500 |
58 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.24804736 |
59 | Impaired smooth pursuit (HP:0007772) | 3.23834367 |
60 | Dysdiadochokinesis (HP:0002075) | 3.21513030 |
61 | Pulmonary infiltrates (HP:0002113) | 3.15765667 |
62 | Keratoconjunctivitis (HP:0001096) | 3.14704141 |
63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.12636290 |
64 | Gastrointestinal infarctions (HP:0005244) | 3.11200066 |
65 | Abnormality of T cell physiology (HP:0011840) | 3.09963295 |
66 | Combined immunodeficiency (HP:0005387) | 3.09522586 |
67 | IgA deficiency (HP:0002720) | 3.05956711 |
68 | Joint swelling (HP:0001386) | 3.05582341 |
69 | Abnormality of eosinophils (HP:0001879) | 3.05125083 |
70 | IgM deficiency (HP:0002850) | 3.04376093 |
71 | Hemoptysis (HP:0002105) | 3.01757648 |
72 | Cerebral inclusion bodies (HP:0100314) | 2.97735312 |
73 | Postural instability (HP:0002172) | 2.95976625 |
74 | Papilledema (HP:0001085) | 2.95820253 |
75 | Urinary urgency (HP:0000012) | 2.90651599 |
76 | Stereotypic behavior (HP:0000733) | 2.90568779 |
77 | Ankle clonus (HP:0011448) | 2.85364453 |
78 | Dysmetric saccades (HP:0000641) | 2.83311431 |
79 | Abnormality of binocular vision (HP:0011514) | 2.83037187 |
80 | Diplopia (HP:0000651) | 2.83037187 |
81 | Annular pancreas (HP:0001734) | 2.82619842 |
82 | Leukocytosis (HP:0001974) | 2.81080460 |
83 | Excessive salivation (HP:0003781) | 2.79803893 |
84 | Drooling (HP:0002307) | 2.79803893 |
85 | Spontaneous hematomas (HP:0007420) | 2.79344220 |
86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.78649298 |
87 | Thyroiditis (HP:0100646) | 2.76224815 |
88 | Scanning speech (HP:0002168) | 2.75806655 |
89 | Agammaglobulinemia (HP:0004432) | 2.73721721 |
90 | Slow saccadic eye movements (HP:0000514) | 2.71196216 |
91 | Eosinophilia (HP:0001880) | 2.71006929 |
92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.70490128 |
93 | Basal cell carcinoma (HP:0002671) | 2.70221153 |
94 | Abnormality of the lower motor neuron (HP:0002366) | 2.69060296 |
95 | Impaired vibratory sensation (HP:0002495) | 2.69050941 |
96 | Inflammation of the large intestine (HP:0002037) | 2.67138446 |
97 | Granulocytopenia (HP:0001913) | 2.63145703 |
98 | Abnormal eating behavior (HP:0100738) | 2.60235383 |
99 | Epileptiform EEG discharges (HP:0011182) | 2.59910285 |
100 | Absent speech (HP:0001344) | 2.59302563 |
101 | Abnormality of macrophages (HP:0004311) | 2.57968802 |
102 | Bradykinesia (HP:0002067) | 2.57481050 |
103 | Neurofibrillary tangles (HP:0002185) | 2.57447475 |
104 | Gastrointestinal inflammation (HP:0004386) | 2.53364943 |
105 | Torticollis (HP:0000473) | 2.52984403 |
106 | Focal dystonia (HP:0004373) | 2.52014358 |
107 | Abnormality of the fingertips (HP:0001211) | 2.49785871 |
108 | Progressive inability to walk (HP:0002505) | 2.48970960 |
109 | Termporal pattern (HP:0011008) | 2.48018570 |
110 | Insidious onset (HP:0003587) | 2.48018570 |
111 | Increased IgE level (HP:0003212) | 2.46434897 |
112 | Genetic anticipation (HP:0003743) | 2.44854883 |
113 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43011173 |
114 | Obstructive lung disease (HP:0006536) | 2.43011173 |
115 | Hypoplasia of the thymus (HP:0000778) | 2.41411886 |
116 | Hemiparesis (HP:0001269) | 2.41025502 |
117 | Spastic gait (HP:0002064) | 2.39017932 |
118 | Abnormality of B cell number (HP:0010975) | 2.37335087 |
119 | Papilloma (HP:0012740) | 2.35668343 |
120 | Verrucae (HP:0200043) | 2.35668343 |
121 | Chest pain (HP:0100749) | 2.35103282 |
122 | Colitis (HP:0002583) | 2.34095771 |
123 | Pulmonary embolism (HP:0002204) | 2.32715033 |
124 | Resting tremor (HP:0002322) | 2.31985644 |
125 | Status epilepticus (HP:0002133) | 2.29240554 |
126 | Mutism (HP:0002300) | 2.27981258 |
127 | Intention tremor (HP:0002080) | 2.26179618 |
128 | Inability to walk (HP:0002540) | 2.24780496 |
129 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24140089 |
130 | Gangrene (HP:0100758) | 2.23392681 |
131 | Hemiplegia (HP:0002301) | 2.21129707 |
132 | Ankyloglossia (HP:0010296) | 2.19622389 |
133 | B lymphocytopenia (HP:0010976) | 2.19027086 |
134 | Pointed chin (HP:0000307) | 2.18580467 |
135 | Lower limb amyotrophy (HP:0007210) | 2.18300420 |
136 | Deep palmar crease (HP:0006191) | 2.18246002 |
137 | Arterial thrombosis (HP:0004420) | 2.14935290 |
138 | Delusions (HP:0000746) | 2.14640417 |
139 | Megalencephaly (HP:0001355) | 2.14438417 |
140 | Lymphoma (HP:0002665) | 2.12208944 |
141 | Gastrointestinal stroma tumor (HP:0100723) | 2.11975754 |
142 | Incomplete penetrance (HP:0003829) | 2.11665057 |
143 | Generalized myoclonic seizures (HP:0002123) | 2.11443067 |
144 | Craniofacial dystonia (HP:0012179) | 2.07951574 |
145 | Autoimmune thrombocytopenia (HP:0001973) | 2.07917123 |
146 | Gait ataxia (HP:0002066) | 2.07157602 |
147 | Hypergammaglobulinemia (HP:0010702) | 2.07010314 |
148 | Lower limb asymmetry (HP:0100559) | 2.06703454 |
149 | Bronchitis (HP:0012387) | 2.06029828 |
150 | Abnormality of the pleura (HP:0002103) | 2.05138496 |
151 | Hypsarrhythmia (HP:0002521) | 2.05028682 |
152 | Blue irides (HP:0000635) | 2.02326880 |
153 | Abnormality of salivation (HP:0100755) | 2.02275333 |
154 | Recurrent sinusitis (HP:0011108) | 2.01885086 |
155 | Psychosis (HP:0000709) | 2.01037846 |
156 | Anorexia (HP:0002039) | 2.00975021 |
157 | Fetal akinesia sequence (HP:0001989) | 2.00494967 |
158 | Hydroureter (HP:0000072) | 1.99950174 |
159 | Ventricular fibrillation (HP:0001663) | 1.99782170 |
160 | Lower limb muscle weakness (HP:0007340) | 1.98484958 |
161 | Keratitis (HP:0000491) | 1.97920984 |
162 | Prolonged bleeding time (HP:0003010) | 1.97906508 |
163 | Chronic otitis media (HP:0000389) | 1.96960212 |
164 | Severe visual impairment (HP:0001141) | 1.95728793 |
165 | Abnormality of oral frenula (HP:0000190) | 1.94691910 |
166 | Inappropriate behavior (HP:0000719) | 1.93943850 |
167 | Protruding tongue (HP:0010808) | 1.92261130 |
168 | Gingivitis (HP:0000230) | 1.92039864 |
169 | Hypochromic anemia (HP:0001931) | 1.91813796 |
170 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91539195 |
171 | Rapidly progressive (HP:0003678) | 1.90799084 |
172 | Deeply set eye (HP:0000490) | 1.87422379 |
173 | Stomach cancer (HP:0012126) | 1.87091361 |
174 | Generalized hypopigmentation of hair (HP:0011358) | 1.83370299 |
175 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82735257 |
176 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82510488 |
177 | Urticaria (HP:0001025) | 1.82222216 |
178 | Osteomyelitis (HP:0002754) | 1.82186382 |
179 | Viral hepatitis (HP:0006562) | 1.81172229 |
180 | Ocular albinism (HP:0001107) | 1.81091181 |
181 | Aqueductal stenosis (HP:0002410) | 1.81001648 |
182 | Abnormality of saccadic eye movements (HP:0000570) | 1.80364088 |
183 | Neuronal loss in central nervous system (HP:0002529) | 1.80063659 |
184 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79013480 |
185 | Widely spaced teeth (HP:0000687) | 1.78299961 |
186 | Rigidity (HP:0002063) | 1.77437316 |
187 | Abnormality of the endocardium (HP:0004306) | 1.76851113 |
188 | Fair hair (HP:0002286) | 1.75759859 |
189 | Thickened helices (HP:0000391) | 1.75451235 |
190 | Testicular atrophy (HP:0000029) | 1.74346825 |
191 | Acne (HP:0001061) | 1.74327445 |
192 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73056586 |
193 | Abnormality of the corticospinal tract (HP:0002492) | 1.73016252 |
194 | Acute hepatic failure (HP:0006554) | 1.72130915 |
195 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.71732010 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 6.22984999 |
2 | NTRK3 | 4.73131912 |
3 | MAP4K1 | 4.59552289 |
4 | RIPK4 | 4.39031983 |
5 | MAP3K9 | 3.47076073 |
6 | DAPK2 | 2.64571212 |
7 | MAP3K4 | 2.58960197 |
8 | KSR2 | 2.47571484 |
9 | TAOK3 | 2.41344593 |
10 | MINK1 | 2.38934204 |
11 | ITK | 2.34335211 |
12 | TYK2 | 2.32860052 |
13 | MAP2K7 | 2.18111248 |
14 | MAP3K13 | 2.17174673 |
15 | NLK | 2.15830881 |
16 | DAPK1 | 2.14496692 |
17 | IKBKE | 2.10448338 |
18 | MAP3K12 | 2.08580742 |
19 | CSK | 2.02777442 |
20 | BTK | 1.97863221 |
21 | PAK6 | 1.90276477 |
22 | JAK1 | 1.89646176 |
23 | PRKD3 | 1.85443200 |
24 | CAMKK1 | 1.81444598 |
25 | BMPR2 | 1.80648915 |
26 | KSR1 | 1.77340877 |
27 | JAK3 | 1.73933798 |
28 | ZAP70 | 1.72480059 |
29 | MAP2K4 | 1.66049375 |
30 | MAP3K14 | 1.65959935 |
31 | ARAF | 1.64787915 |
32 | FES | 1.63521249 |
33 | IRAK4 | 1.63311737 |
34 | SIK2 | 1.57957625 |
35 | BLK | 1.55674374 |
36 | LCK | 1.55294419 |
37 | NTRK1 | 1.54780222 |
38 | PLK2 | 1.49819654 |
39 | CDK5 | 1.49696831 |
40 | TEC | 1.49311702 |
41 | NTRK2 | 1.49086548 |
42 | MAP3K10 | 1.47535240 |
43 | PTK2B | 1.46113759 |
44 | FGFR3 | 1.42930222 |
45 | PASK | 1.35531023 |
46 | PRPF4B | 1.33976575 |
47 | GRK5 | 1.32280499 |
48 | RAF1 | 1.30743379 |
49 | MAP3K2 | 1.29414543 |
50 | CDK19 | 1.29105131 |
51 | CASK | 1.26606322 |
52 | STK38 | 1.22596940 |
53 | PNCK | 1.22064948 |
54 | MARK1 | 1.16898259 |
55 | LYN | 1.13245983 |
56 | PRKCG | 1.12189159 |
57 | TNIK | 1.12143280 |
58 | TYRO3 | 1.11839187 |
59 | JAK2 | 1.07990110 |
60 | FGFR4 | 1.06544900 |
61 | MARK3 | 1.06362714 |
62 | CAMK2B | 1.05923672 |
63 | EPHB1 | 1.05875570 |
64 | CAMK2A | 1.04445802 |
65 | CAMKK2 | 1.01595286 |
66 | TAOK1 | 0.95200784 |
67 | PDK1 | 0.95004836 |
68 | MAP2K3 | 0.94207245 |
69 | HIPK2 | 0.91439455 |
70 | IKBKB | 0.90950054 |
71 | CAMK1 | 0.89128403 |
72 | GRK6 | 0.88868307 |
73 | FGR | 0.88071111 |
74 | PRKCH | 0.87762437 |
75 | TNK2 | 0.85186534 |
76 | RET | 0.81368479 |
77 | MAP3K7 | 0.80922744 |
78 | STK11 | 0.78355852 |
79 | NME1 | 0.76678235 |
80 | SGK1 | 0.76190446 |
81 | MAP3K1 | 0.75373866 |
82 | CDK18 | 0.75149626 |
83 | PDPK1 | 0.73200131 |
84 | SGK2 | 0.72894101 |
85 | CDK15 | 0.71589899 |
86 | YES1 | 0.70769323 |
87 | FRK | 0.70684020 |
88 | CDK14 | 0.69522549 |
89 | SIK3 | 0.69495558 |
90 | SGK494 | 0.68627531 |
91 | SGK223 | 0.68627531 |
92 | TBK1 | 0.68443489 |
93 | MAP3K11 | 0.68285440 |
94 | SGK3 | 0.67874787 |
95 | UHMK1 | 0.67819676 |
96 | MAP2K6 | 0.66297179 |
97 | MAPK13 | 0.64511427 |
98 | MAPK11 | 0.63794093 |
99 | PIM1 | 0.62480956 |
100 | CDK11A | 0.62049293 |
101 | WNK1 | 0.61859589 |
102 | MAP3K3 | 0.60528374 |
103 | STK10 | 0.59031553 |
104 | SYK | 0.57990870 |
105 | CSF1R | 0.56243143 |
106 | FGFR2 | 0.55569417 |
107 | MELK | 0.53769376 |
108 | PINK1 | 0.53638312 |
109 | FYN | 0.53175560 |
110 | MARK2 | 0.52787488 |
111 | DYRK1A | 0.52438962 |
112 | PDGFRB | 0.50732972 |
113 | IRAK1 | 0.50169411 |
114 | DMPK | 0.49639490 |
115 | PIK3CG | 0.49326095 |
116 | CDK4 | 0.49293490 |
117 | PAK3 | 0.47131837 |
118 | TXK | 0.46505792 |
119 | BRD4 | 0.46410900 |
120 | EPHA3 | 0.45718355 |
121 | ALK | 0.45286217 |
122 | OXSR1 | 0.44342800 |
123 | CDK12 | 0.42305928 |
124 | RPS6KA3 | 0.41485469 |
125 | MAPK10 | 0.41330423 |
126 | MAP2K1 | 0.40786590 |
127 | DAPK3 | 0.39772067 |
128 | NUAK1 | 0.38794603 |
129 | CAMK4 | 0.38422624 |
130 | CAMK2D | 0.38189031 |
131 | PRKCZ | 0.37191666 |
132 | PIK3CA | 0.37065426 |
133 | CAMK2G | 0.33902390 |
134 | PRKD2 | 0.33669103 |
135 | PRKCE | 0.33528587 |
136 | NEK6 | 0.31552192 |
137 | HCK | 0.31267998 |
138 | * PRKCQ | 0.31208980 |
139 | PRKCB | 0.31101523 |
140 | CDK6 | 0.30203327 |
141 | EGFR | 0.29810351 |
142 | MOS | 0.27616055 |
143 | MAPK12 | 0.27263693 |
144 | PRKCA | 0.26725937 |
145 | MAPK7 | 0.26441370 |
146 | CAMK1G | 0.24376588 |
147 | FER | 0.24257873 |
148 | ROCK2 | 0.23297349 |
149 | CSNK1G2 | 0.22669506 |
150 | BRAF | 0.22538044 |
151 | CSNK1A1 | 0.21316263 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.93501628 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.59513269 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.17373268 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78050755 |
5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.75319371 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72304198 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67804884 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61946147 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61921247 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60514426 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.60080401 |
12 | Morphine addiction_Homo sapiens_hsa05032 | 2.51665732 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49187417 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39890061 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.37286426 |
16 | Salivary secretion_Homo sapiens_hsa04970 | 2.35614188 |
17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19331955 |
18 | Measles_Homo sapiens_hsa05162 | 2.14747645 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10833061 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03108430 |
21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96206488 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92750704 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.91008250 |
24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.90982965 |
25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87295663 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.85416818 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77347512 |
28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75807864 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71697366 |
30 | Long-term depression_Homo sapiens_hsa04730 | 1.69918719 |
31 | Taste transduction_Homo sapiens_hsa04742 | 1.69024661 |
32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63293103 |
33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58837085 |
34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58604667 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57788365 |
36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56867301 |
37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56687011 |
38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56419101 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53464222 |
40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52967075 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52444186 |
42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48827850 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46162597 |
44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.40889249 |
45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.39883746 |
46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38923259 |
47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32751785 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.32695717 |
49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30179319 |
50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28952430 |
51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27014817 |
52 | Gap junction_Homo sapiens_hsa04540 | 1.24727128 |
53 | Glioma_Homo sapiens_hsa05214 | 1.24625859 |
54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19922780 |
55 | Influenza A_Homo sapiens_hsa05164 | 1.13269609 |
56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12536238 |
57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10039730 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08234711 |
59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07421245 |
60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06627495 |
61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04372347 |
62 | Melanogenesis_Homo sapiens_hsa04916 | 1.02297320 |
63 | Malaria_Homo sapiens_hsa05144 | 1.01754843 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00492541 |
65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00361463 |
66 | Asthma_Homo sapiens_hsa05310 | 0.99539353 |
67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98695568 |
68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98142172 |
69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97372178 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96435497 |
71 | Hepatitis C_Homo sapiens_hsa05160 | 0.95787247 |
72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95376831 |
73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93457384 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93420426 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93390290 |
76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91218271 |
77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90321732 |
78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89737567 |
79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89382454 |
80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87643713 |
81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87301240 |
82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86711231 |
83 | Axon guidance_Homo sapiens_hsa04360 | 0.85670841 |
84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85115833 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83712053 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83269659 |
87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82835384 |
88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80811378 |
89 | Apoptosis_Homo sapiens_hsa04210 | 0.80161207 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79101595 |
91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76625254 |
92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76304405 |
93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73894130 |
94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73334802 |
95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70984539 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70390770 |
97 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70359847 |
98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68487302 |
99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68201014 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68078268 |
101 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67834259 |
102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67721285 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66798285 |
104 | Phototransduction_Homo sapiens_hsa04744 | 0.65538405 |
105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64359911 |
106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63488074 |
107 | Prostate cancer_Homo sapiens_hsa05215 | 0.63434569 |
108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62609352 |
109 | Legionellosis_Homo sapiens_hsa05134 | 0.61675475 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61062061 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60841911 |
112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60181005 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59245230 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57730052 |
115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57705630 |
116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57176828 |
117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53610192 |
118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53461638 |
119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52725082 |
120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52642243 |
121 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.52469832 |
122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50836826 |
123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49610085 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.48576896 |
125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46368399 |
126 | Endocytosis_Homo sapiens_hsa04144 | 0.45887946 |
127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42708476 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.40902121 |
129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38859134 |
130 | Alcoholism_Homo sapiens_hsa05034 | 0.38759379 |
131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37094552 |
132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35999268 |
133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35236000 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.35101540 |
135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35054620 |
136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34864753 |
137 | Tuberculosis_Homo sapiens_hsa05152 | 0.34628226 |
138 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34354275 |
139 | Salmonella infection_Homo sapiens_hsa05132 | 0.33176996 |
140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31449322 |
141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31362538 |
142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31001261 |
143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30919667 |
144 | * Platelet activation_Homo sapiens_hsa04611 | 0.30543821 |
145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29670280 |
146 | Bile secretion_Homo sapiens_hsa04976 | 0.27809539 |
147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27580286 |
148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27436919 |
149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27089832 |